Virtualscopics (VSCP) 3.49 $VSCP
VirtualScopics, Inc. Schedules Fourth Quarter And Year End 2014 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Fri Feb 13, 10:00AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its fourth quarter and year end 2014 financial results before the market opens on Thursday, February 26, 2015. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. Conference call, webcast and replay information is as follows:
VSCP: 3.49 (+0.19)
Andrew Levitch And Michael Woehler, Ph.D. Join Virtualscopics, Inc.'s Board Of Directors; David Rubin, Ph.D. Announces Retirement From The Board
PR Newswire - Wed Feb 11, 12:30PM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that David Rubin, 49, a director representing the Series C shares of the company's stock since 2012, is retiring from the board of directors, effective today. Joining the company in the Series C shares director position is Andrew Levitch, MBA, 52. The company also announced that it is expanding its board of directors with the addition of Michael Woehler, 69. Both appointments are effective today.
VSCP: 3.49 (+0.19)
VirtualScopics Licences IXICO's Proprietary TrialTracker(TM) Digital Platform
PR Newswire - Tue Dec 16, 6:30AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that they have signed a multi-year software licence and support agreement with existing alliance partner, IXICO plc (Ticker: IXI) ("IXICO" or the "Company"
, the brain health company, for their proprietary imaging data and query management digital platform, TrialTracker(TM).
VSCP: 3.49 (+0.19)
VirtualScopics' (VSCP) CEO Eric Converse on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 12:11PM CST
VSCP: 3.49 (+0.19)
VirtualScopics EPS of -$0.33
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 8:27AM CST
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Reports Third Quarter And Nine Months 2014 Financial Results; Third Quarter Awards Outstanding And Bookings Up 29%, Quarterly Revenues Up 23% From The Prior Year
PR Newswire - Thu Nov 13, 5:00AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the third quarter and nine months ended September 30, 2014. Awards outstanding and bookings as of and for the nine months ended September 30, 2014 increased 29% to $23.8 million, as compared to $18.4 million for the same period in 2013. Awards outstanding and bookings as of and for the year to date period ended today, November 13, 2014 are approximately $25.5 million, 124% of the $20.5 million as of and for the fiscal year ended December 31, 2013.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, November 13, 2014
ACCESSWIRE - Wed Nov 12, 3:45PM CST
ROCHESTER, NY / ACCESSWIRE / November 12, 2014 / VirtualScopics, Inc. (NASDAQ:VSCP) will host a conference call and live webcast to discuss the results of the third quarter 2014, to be held Thursday, November 13, 2014 at 8:30 AM Eastern Time.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Schedules Third Quarter 2014 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Mon Nov 03, 3:05PM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its third quarter and nine months 2014 financial results before the market opens on Thursday, November 13, 2014. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. Conference call, webcast and replay information is as follows:
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Names James Groff Chief Financial Officer
PR Newswire - Thu Aug 21, 7:00AM CDT
The board of directors of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that James Groff, 44, has been named chief financial officer, effective immediately. Mr. Groff has held the role of acting chief financial officer since August 2013. He joined VirtualScopics in January 2006 as an accounting manager and was promoted to controller in February 2013.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Reports Second Quarter and Six Months 2014 Financial Results; Awards Outstanding and Bookings Reflect a Two-Fold Increase Over 2013 First Six Months
PR Newswire - Thu Aug 14, 5:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today reported the financial results for the second quarter and six months ended June 30, 2014. Awards outstanding and bookings for the first six months of 2014 increased to $17.6 million, more than double the $7.7 million reported during the same period in 2013. Year to date 2014 awards outstanding and bookings are approximately $23.5 million, 115% of the $20.5 million recognized in the full year 2013 with over four months still left in the year.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 14, 2014
ACCESSWIRE - Wed Aug 13, 3:14PM CDT
ROCHESTER, NY / ACCESSWIRE / August 13, 2014 / VirtualScopics, Inc. (NASDAQ:VSCP) will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Thursday, August 14, 2014 at 8:30 AM Eastern Time.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Schedules Second Quarter 2014 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Tue Aug 05, 8:00AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its second quarter and six months 2014 financial results before the market opens on Thursday, August 14, 2014. Eric T. Converse, president and chief executive officer, and Jim Groff, acting chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. Conference call, webcast and replay information is as follows:
VSCP: 3.49 (+0.19)
Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc.
PR Newswire - Wed Jul 23, 1:30PM CDT
The Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric T. Converse, 48, has been named president and chief executive officer, effective immediately. Mr. Converse joined the company's Board of Directors in August 2013 and has held the positions of interim president and chief executive officer since October 25, 2013.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman
PR Newswire - Mon Jul 14, 3:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP) and IXICO plc (AIM: IXI) jointly announced today the formation of a Scientific Advisory Board that will benefit both companies. Dr. Edward Ashton, Ph.D., chief scientific officer, VirtualScopics, will chair the Board which initially will have seven members.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. And IXICO plc Open Operations And Business Development Office In New Hope, PA
PR Newswire - Mon Jun 30, 3:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, announced today they are jointly leasing 2,190 sq. ft. of office space in New Hope, Pennsylvania, strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania. The office will be located at 220 Union Square Drive, located within the Union Square office complex in New Hope. Staffing for the office will begin immediately.
VSCP: 3.49 (+0.19)
IXICO, plc Signs an Alliance Framework Agreement With VirtualScopics, Inc.
PR Newswire Europe - Fri Jun 27, 7:16AM CDT
LONDON and ROCHESTER, New York, June 27, 2014 /PRNewswire/ --
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Signs An Alliance Framework Agreement With IXICO plc; Commercial And Operational Alliance To Provide Clinical Trials Industry With Global Capabilities And A Full Range Of Therapeutic Areas And Modality Expertise
PR Newswire - Fri Jun 27, 3:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, today said they have signed an Alliance Framework Agreement and Master Subcontractor Agreement previously announced as an agreement in principle on March 7, 2014. This alliance will provide the clinical trials industry with global operational capabilities and a full range of therapeutic areas and modality expertise. The alliance enhances both companies' abilities to deliver world-class services to pharmaceutical, biotech and academic customers and collaborators around the globe.
VSCP: 3.49 (+0.19)
Nasdaq stocks posting largest percentage decreases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
VSCP: 3.49 (+0.19), AMTX: 4.52 (+0.13), GLYC: 7.77 (+0.12), BIOC: 1.41 (+0.22), COVS: 2.47 (+0.11), NCIT: 11.49 (-0.32)
VirtualScopics, Inc. Schedules Fourth Quarter And Year End 2014 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Fri Feb 13, 10:00AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its fourth quarter and year end 2014 financial results before the market opens on Thursday, February 26, 2015. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. Conference call, webcast and replay information is as follows:
VSCP: 3.49 (+0.19)
Andrew Levitch And Michael Woehler, Ph.D. Join Virtualscopics, Inc.'s Board Of Directors; David Rubin, Ph.D. Announces Retirement From The Board
PR Newswire - Wed Feb 11, 12:30PM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that David Rubin, 49, a director representing the Series C shares of the company's stock since 2012, is retiring from the board of directors, effective today. Joining the company in the Series C shares director position is Andrew Levitch, MBA, 52. The company also announced that it is expanding its board of directors with the addition of Michael Woehler, 69. Both appointments are effective today.
VSCP: 3.49 (+0.19)
VirtualScopics Licences IXICO's Proprietary TrialTracker(TM) Digital Platform
PR Newswire - Tue Dec 16, 6:30AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that they have signed a multi-year software licence and support agreement with existing alliance partner, IXICO plc (Ticker: IXI) ("IXICO" or the "Company"
, the brain health company, for their proprietary imaging data and query management digital platform, TrialTracker(TM). VSCP: 3.49 (+0.19)
VirtualScopics' (VSCP) CEO Eric Converse on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 12:11PM CST
VSCP: 3.49 (+0.19)
VirtualScopics EPS of -$0.33
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 8:27AM CST
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Reports Third Quarter And Nine Months 2014 Financial Results; Third Quarter Awards Outstanding And Bookings Up 29%, Quarterly Revenues Up 23% From The Prior Year
PR Newswire - Thu Nov 13, 5:00AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the third quarter and nine months ended September 30, 2014. Awards outstanding and bookings as of and for the nine months ended September 30, 2014 increased 29% to $23.8 million, as compared to $18.4 million for the same period in 2013. Awards outstanding and bookings as of and for the year to date period ended today, November 13, 2014 are approximately $25.5 million, 124% of the $20.5 million as of and for the fiscal year ended December 31, 2013.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, November 13, 2014
ACCESSWIRE - Wed Nov 12, 3:45PM CST
ROCHESTER, NY / ACCESSWIRE / November 12, 2014 / VirtualScopics, Inc. (NASDAQ:VSCP) will host a conference call and live webcast to discuss the results of the third quarter 2014, to be held Thursday, November 13, 2014 at 8:30 AM Eastern Time.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Schedules Third Quarter 2014 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Mon Nov 03, 3:05PM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its third quarter and nine months 2014 financial results before the market opens on Thursday, November 13, 2014. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. Conference call, webcast and replay information is as follows:
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Names James Groff Chief Financial Officer
PR Newswire - Thu Aug 21, 7:00AM CDT
The board of directors of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that James Groff, 44, has been named chief financial officer, effective immediately. Mr. Groff has held the role of acting chief financial officer since August 2013. He joined VirtualScopics in January 2006 as an accounting manager and was promoted to controller in February 2013.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Reports Second Quarter and Six Months 2014 Financial Results; Awards Outstanding and Bookings Reflect a Two-Fold Increase Over 2013 First Six Months
PR Newswire - Thu Aug 14, 5:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today reported the financial results for the second quarter and six months ended June 30, 2014. Awards outstanding and bookings for the first six months of 2014 increased to $17.6 million, more than double the $7.7 million reported during the same period in 2013. Year to date 2014 awards outstanding and bookings are approximately $23.5 million, 115% of the $20.5 million recognized in the full year 2013 with over four months still left in the year.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 14, 2014
ACCESSWIRE - Wed Aug 13, 3:14PM CDT
ROCHESTER, NY / ACCESSWIRE / August 13, 2014 / VirtualScopics, Inc. (NASDAQ:VSCP) will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Thursday, August 14, 2014 at 8:30 AM Eastern Time.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Schedules Second Quarter 2014 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Tue Aug 05, 8:00AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its second quarter and six months 2014 financial results before the market opens on Thursday, August 14, 2014. Eric T. Converse, president and chief executive officer, and Jim Groff, acting chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. Conference call, webcast and replay information is as follows:
VSCP: 3.49 (+0.19)
Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc.
PR Newswire - Wed Jul 23, 1:30PM CDT
The Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric T. Converse, 48, has been named president and chief executive officer, effective immediately. Mr. Converse joined the company's Board of Directors in August 2013 and has held the positions of interim president and chief executive officer since October 25, 2013.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman
PR Newswire - Mon Jul 14, 3:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP) and IXICO plc (AIM: IXI) jointly announced today the formation of a Scientific Advisory Board that will benefit both companies. Dr. Edward Ashton, Ph.D., chief scientific officer, VirtualScopics, will chair the Board which initially will have seven members.
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. And IXICO plc Open Operations And Business Development Office In New Hope, PA
PR Newswire - Mon Jun 30, 3:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, announced today they are jointly leasing 2,190 sq. ft. of office space in New Hope, Pennsylvania, strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania. The office will be located at 220 Union Square Drive, located within the Union Square office complex in New Hope. Staffing for the office will begin immediately.
VSCP: 3.49 (+0.19)
IXICO, plc Signs an Alliance Framework Agreement With VirtualScopics, Inc.
PR Newswire Europe - Fri Jun 27, 7:16AM CDT
LONDON and ROCHESTER, New York, June 27, 2014 /PRNewswire/ --
VSCP: 3.49 (+0.19)
VirtualScopics, Inc. Signs An Alliance Framework Agreement With IXICO plc; Commercial And Operational Alliance To Provide Clinical Trials Industry With Global Capabilities And A Full Range Of Therapeutic Areas And Modality Expertise
PR Newswire - Fri Jun 27, 3:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, today said they have signed an Alliance Framework Agreement and Master Subcontractor Agreement previously announced as an agreement in principle on March 7, 2014. This alliance will provide the clinical trials industry with global operational capabilities and a full range of therapeutic areas and modality expertise. The alliance enhances both companies' abilities to deliver world-class services to pharmaceutical, biotech and academic customers and collaborators around the globe.
VSCP: 3.49 (+0.19)
Nasdaq stocks posting largest percentage decreases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
VSCP: 3.49 (+0.19), AMTX: 4.52 (+0.13), GLYC: 7.77 (+0.12), BIOC: 1.41 (+0.22), COVS: 2.47 (+0.11), NCIT: 11.49 (-0.32)
